Sg3 Management, LLC Takeda Pharmaceutical CO LTD Call Options Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $981,649 - $1.11 Million	-72,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $1.13 Million - $1.34 Million	67,500 Added 1350.0%	72,500 $1.32 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $72,950 - $97,500	5,000 New	5,000 $90,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.